{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-024777","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.013604+00:00","generated_at":"2026-05-15T18:36:50.335825+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CorMedix reaffirms FY2027 DefenCath guidance $100M-$140M; FY2026 revenue guidance $300M-$320M","bullets":["Reaffirms FY2027 DefenCath sales $100M-$140M, correcting inadvertent $100M-$125M range from March 5 earnings call.","FY2026 guidance: revenue $300M-$320M, adjusted EBITDA $100M-$125M, DefenCath sales $150M-$170M.","Q4 2025 net revenue $129M, DefenCath sales $91M; FY2025 pro forma net revenue $401M.","Pipeline milestones: REZZAYO prophylaxis Ph3 data expected Q2 2026; DefenCath TPN (NUTRI-LOCK) data 1H 2027.","Balance sheet at Dec 31 2025: cash & short-term investments $149M, convertible debt $150M, shares outstanding 79.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-024777","json":"https://secwatch.observer/filing/0001213900-26-024777.json","markdown":"https://secwatch.observer/filing/0001213900-26-024777.md","text":"https://secwatch.observer/filing/0001213900-26-024777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026024777/0001213900-26-024777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026024777/ea0280394-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:36:50.335825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}